Myelodysplastic Syndromes (MDS)and Acute Myeloid Leukaemia (AML Flashcards
define myelodysplatic syndromes
myelo- marrow
dysplastic- abnormal or funny looking
describe myelodysplatic syndromes ( L)
-proportion of leukaemia cells or blasts <20% nucleated cels in bone marrow
=Bone marrow cells fail to make adequate numbers of healthy blood cells
i.e. both quantity and quality (function) of cells are affected
-Abnormal cells crowd out remaining normal cells
what is can myelodysplatic syndromes progress to?
acute myeloid leukaemia
What is Acute Myeloid Leukaemia?
Acute myeloid leukaemia (AML) is a heterogeneous clonal malignancy characterised by
-immature myeloid cell proliferation (defined as ≥20% “blasts”)
and
-bone marrow failure
describe the epidemiology of MDS
4.5 in 100,000
Median age at diagnosis = 76 years
describe the epidemiology of AML
less than 1% each year
age 85-89
what are the diagnostic features of MDS in a full blood count blood test? ( L)
Low blood counts
-red cells (symptoms include fatigue, shortness of breath, lightheadedness)
-white cells (symptoms include increased risk of frequent and/or severe infections)
-platelets (bleeding/ bruising)
-Peripheral blood film demonstrates dysplastic features (e.g. hypogranular neutrophils, platelet anisopoikilocytosis, blasts)
what are the diagnostic features of AML in a full blood count blood test?
White cell counts can be
-Low
-Normal
-High
-symptoms include increased risk of frequent and/or severe infections (because a large proportion of the white cells are abnormal)
-Other blood parameters are usually low
–red cells (symptoms include fatigue, shortness of breath, lightheadedness)
-platelets (symptoms of bleeding/ bruising)
What are the potential differential diagnoses
B12/ folate or mixed haematinic deficiency
Infection (e.g. retroviral disease, herpesvirus)
Medications
Autoimmune
Liver disease (e.g. cirrhosis)
post operative
severe sepsis- Blasts in peripheral blood usually associated with neutrophil
in a patient with suspected MDS/AML what investigations should you do?
-A good history
-Review of previous blood test results
—Was the FBC previously normal?
–Has the Hb/ WC/ neutrophils/ platelet counts been downward trending for some weeks/ months/ years?
-FBC and blood film
-Haematinics (B12, folate, ferritin)
when should you be concerned? ( L)
-There are blasts on peripheral blood
-The deterioration in FBC parameters is very rapid (days/ weeks)
-Have a low threshold for all other patients to repeat FBC in 1-2 weeks and tell them to ring if they notice any new symptoms (i.e. symptomatic anaemia, infection, bleeding/ bruising)
how do you diagnose MDS and AML
Blood tests (full blood count & blood film)
Bone marrow aspirate and trephine biopsy
What is morphology?
= the appearance of cells on slides
in morphology what are the requirements for myelodysplastic syndrome?
Requirement of 10% dysplasia in any cell line(s)
Blast % can be anywhere from 0 – 19%
in morphology what are the requirements for acute myeloid leukaemia syndrome?
minimum 20% blasts
define leukemia
malignant proliferation of haemopoietic cells
what history is relevant when diagnosing leukaemia ?
-Anaemia
—–Fatigue
——Shortness of breath
-Infection
—–Tonsillitis
—–Fevers/ rigors
-Thrombocytopenia
–Bruising
–Bleeding – mucosal usually
–Rash
Low haemoglobin
Low platelets
Very low neutrophils
Blast cells present with Auer rods = acute myeloid leukaemia
what tests do you do/ what do you look at to diagnose patients?
-Blood tests (morphology, cytogenetics, minimal residual disease monitoring, molecular genetics, deep sequencing, multi-parameter flow cytometry)
-Bone marrow aspirate and trephine biopsy
-Increase in blasts >20% (acute leukaemia)
-Background abnormalities to suggest pre-existing bone marrow abnormalities
-Cytogenetics for prognosis
-Molecular genetics for prognosis
-Immunophenotyping
describe the onset of Chronic myeloid leukaemia
slow
describe Chronic myeloid leukaemia film
left shift+ basophilia
describe the Chronic myeloid leukaemia WCC
in a FBC- high WCC
what is a key diagnostic feature of Chronic myeloid leukaemia
Philadelphia chromosome
what treatments are used in Chronic myeloid leukaemia
arget molecular therapy – tyrosine kinase inhibitors: Imatinib
AML treatment
Chemotherapy and supportive measures
Take into account – age, fitness, comorbidities, AML features, clinical trials
what is the Most common paediatric malignancy?
Acute lymphoblastic leukaemia